ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf040 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Yang Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Inducible T-Cell Co-Stimulator Protein, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Jinhua Science and Technology Planning Project, National Natural Science Foundation of China, Shanghai Shenkang Clinical Development Center.
Abstract (Originalsprache)
Inducible Co-Stimulator (ICOS), as a T-cell–specific costimulatory receptor that enhances T-cell responses to foreign antigens, plays a crucial role in cancer immunity. However, its role in MSS/pMMR colorectal cancer (CRC) remains unclear. In this study, we demonstrated that ICOS expression decreases as the tumor stages advance and that high ICOS expression is associated with a favorable prognosis in MSS/pMMR CRC. Mechanistically, ICOS promoted the secretion of IFN-γ, TNF-α, and IL-12 in CD4+ T cells through the Akt/STAT1/T-bet axis, leading to the inhibition of MSS/pMMR-CRC-cell proliferation. Importantly, ICOS+ CD4+ T cells enhanced tumor responses to anti-PD-1 therapy in MSS/pMMR CRC. In conclusion, this study revealed that ICOS mediates antitumor immunity by promoting the secretion of cancer-suppressive cytokines. It also suggests that activation of ICOS serves a potential therapeutic strategy for MSS/pMMR CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of General Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center.
- Department of Hepatopancreatobiliary Surgery, Jinhua Central Hospital, Teaching Hospital of Mathematical Medicine College, Zhejiang Normal University, Zhejiang, China.
ORCID-Profile: Yongheng Zhao
Förderung
- Jinhua Science and Technology Planning Project
- National Natural Science Foundation of China
- Shanghai Shenkang Clinical Development Center
- Jinhua Science and Technology Planning
Zitieren
APA
Luo, Y., Li, H., Fang, H., Gong, T., Zhao, Y., Cao, W., Yu, M., Wang, T., Lin, H., & Zhong, M. (2025). ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf040
Vancouver
Luo Y, Li H, Fang H, Gong T, Zhao Y, Cao W, et al. ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf040
BibTeX
@article{Luo2025,
author = {Luo, Yang and Li, Hao and Fang, Hongsheng and Gong, Tingyue and Zhao, Yongheng and Cao, Wenyan and Yu, Minhao and Wang, Tingfeng and Lin, Haiping and Zhong, Ming},
title = {ICOS+ CD4+ T cells promote antitumor immunity through Akt/STAT1/T-bet axis in MSS/pMMR colorectal cancer},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf040}
}
EUVIMED